Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking

被引：5
作者：
De Backer, Daniel [1 ]
Taccone, Fabio Silvio [1 ]
Radermacher, Peter [1 ]
机构：
[1] Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium
来源：
INTENSIVE CARE MEDICINE | 2007年 / 33卷 / 03期
关键词：
D O I：
10.1007/s00134-006-0520-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：403 / 405
页数：3
相关论文
共 26 条
[1]   Clinical review: Influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock [J].
Asfar, P ;
De Backer, D ;
Meier-Hellmann, A ;
Radermacher, P ;
Sakka, SG .
CRITICAL CARE, 2004, 8 (03) :170-179
[2]   The calcium sensitizer levosimendan attenuates endotoxin-evoked myocardial dysfunction in isolated guinea pig hearts [J].
Behrends, M ;
Peters, J .
INTENSIVE CARE MEDICINE, 2003, 29 (10) :1802-1807
[3]   The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects [J].
De Backer, D ;
Creteur, J ;
Dubois, MJ ;
Sakr, Y ;
Koch, M ;
Verdant, C ;
Vincent, JL .
CRITICAL CARE MEDICINE, 2006, 34 (02) :403-408
[4]   Microvascular blood flow is altered in patients with sepsis [J].
De Backer, D ;
Creteur, J ;
Preiser, JC ;
Dubois, MJ ;
Vincent, JL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :98-104
[5]   Does hepato-splanchnic Vo2/Do2 dependency exist in critically ill septic patients? [J].
De Backer, D ;
Creteur, J ;
Noordally, O ;
Smail, N ;
Gulbis, B ;
Vincent, JL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) :1219-1225
[6]  
DUBIN A, 2006, INTENS CARE MED, DOI DOI 10.1007/S00134-006-519-5
[7]   HETEROGENEOUS REGIONAL VASCULAR-RESPONSES TO SIMULATED TRANSIENT HYPOVOLEMIA IN MAN [J].
EDOUARD, AR ;
DEGREMONT, AC ;
DURANTEAU, J ;
PUSSARD, E ;
BERDEAUX, A ;
SAMII, K .
INTENSIVE CARE MEDICINE, 1994, 20 (06) :414-420
[8]   Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits [J].
Faivre, V ;
Kaskos, H ;
Callebert, J ;
Losser, MR ;
Milliez, P ;
Bonnin, P ;
Payen, D ;
Mebazaa, A .
ANESTHESIOLOGY, 2005, 103 (03) :514-521
[9]   Levosimendan is a mitochondrial KATP channel opener [J].
Kopustinskiene, DM ;
Pollesello, P ;
Saris, NEL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 428 (03) :311-314
[10]   Potassium-specific effects of levosimendan on heart mitochondria [J].
Kopustinskiene, DM ;
Pollesello, P ;
Saris, NEL .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (05) :807-812
123